In one published incident, fatal adult respiratory distress syndrome occurred rapidly following infusion of > 1010 T-cells, targeted against ErbB2 using a trastuzumab scFv coupled to a fused CD28/4-1BB/CD3ζ endoplasmic domain [29]. Here, CD247 is linked to acute respiratory distress syndrome.